High-Frequency Gene Modification in Human Cells Using Non-Integrative Lentivirus
Author Information
Author(s): Raul García Torres, Aida Payá, Monica Ramirez, Juan C. Rossi
Primary Institution: Fundación Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
Hypothesis
Can a non-integrative lentivirus effectively drive high-frequency recombinase-mediated cassette exchange (RMCE) in human cells?
Conclusion
The study demonstrates that a novel strategy using integrase-deficient lentivirus can achieve high-frequency gene modification in human cells through RMCE.
Supporting Evidence
- The method achieved RMCE frequencies ranging from 3.5×10−4 to 1.5×10−5.
- All recovered clones were selected as a result of RMCE.
- Frequencies of RMCE were reported to be 1,000-fold to 100,000-fold higher than previous methods.
Takeaway
Scientists found a new way to change genes in human cells safely and easily using a special virus that doesn't stick to the DNA.
Methodology
The study used integrase-deficient lentiviral vectors to promote RMCE in human embryonic kidney cells, measuring the frequency of successful gene modifications.
Limitations
The study primarily tested the method in specific cell lines, which may limit its applicability to other cell types.
Participant Demographics
Human embryonic kidney cell lines (HEK293A and HEK293T) were used.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website